dr. matthew mossanen with an overview of risk factors for bladder cancer
Published 2 years ago • 43 plays • Length 2:48Download video MP4
Download video MP3
Similar videos
-
2:16
dr. matthew mossanen on the impact of neoadjuvant chemotherapy on bladder cancer outcomes
-
2:27
dr. matthew mossanen on impact of smoking on outcomes after radical cystectomy for bladder cancer
-
5:16
smoking cessation and bladder cancer
-
4:38
optimal sequence of therapies for bladder cancer
-
0:58
what are the risk factors for bladder cancer? penn state cancer institute
-
4:39
durvalumab as neoadjuvant therapy for muscle-invasive bladder cancer
-
49:28
pnh: intravascular hemolysis and extravascular hemolysis
-
43:17
case-based panel discussion: muscle-invasive bladder cancer
-
5:16
medical importance of exercise with a bladder cancer diagnosis
-
7:45
analysis of recurrence after neoadjuvant bladder cancer treatment: practical implications
-
4:41
management strategies for non-muscle-invasive bladder cancer
-
10:03
genitourinary tumor board: bladder cancer
-
4:03
the impact of obesity on the outcomes after radical cystectomy
-
56:38
management of urothelial bladder cancer with dr matthew galsky
-
4:52
surgical approaches in bladder cancer: robotic vs open cystectomy
-
7:48
genitourinary tumor board: bladder cancer diagnosis
-
4:54
use of bcg in non-muscle-invasive bladder cancer
-
6:37
practical issues with use of edrafitinib in urothelial carcinoma
-
1:09:47
evidence and insights on innovative treatment for bladder cancer
-
3:18
practical approaches to bcg unresponsive bladder cancer
-
3:47
bcg shortage and changing treatment patterns for non-muscle-invasive bladder cancer